MedTrace Logo

Who Will Benefit From Bariatric Surgery for Diabetes?

NCT03842475 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2023-04-19

No results posted yet for this study

Summary

A study investigating the influence of fat distribution, genetic susceptibility markers for type 2 diabetes (T2DM) and fat distribution, epigenetic and transcriptomic changes and gut hormone responses to a mixed meal on diabetes remission following bariatric surgery.

Conditions

  • Diabetes Mellitus, Type 2
  • Obesity

Interventions

PROCEDURE

Roux-en-Y gastric bypass (RYGB)

Bariatric surgery

Sponsors & Collaborators

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • Imperial College London

    lead OTHER

Principal Investigators

  • Tricia Tan, MB ChB · Imperial College London

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2025-01-01
Completion
2028-10-05

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03842475 on ClinicalTrials.gov